SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol.
Saved in:
| Title: | SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol. |
|---|---|
| Authors: | McCarthy, Caroline1 (AUTHOR) carolmc2@liverpool.ac.uk, Sacco, Joseph2 (AUTHOR), Fedele, Stefano3 (AUTHOR), Ho, Michael4 (AUTHOR), Porter, Stephen5 (AUTHOR), Liloglou, Triantafillos2 (AUTHOR), Greenhalf, Bill6 (AUTHOR), Robinson, Max7 (AUTHOR), Young, Bridget8 (AUTHOR), Cicconi, Silvia9 (AUTHOR), Chauhan, Seema10 (AUTHOR), Tesfaye, Binyam11 (AUTHOR), Jackson, Richard9 (AUTHOR), Sherratt, Frances12 (AUTHOR), Shaw, Richard13 (AUTHOR) |
| Source: | Trials. 7/5/2021, Vol. 22 Issue 1, p1-12. 12p. 1 Diagram, 5 Charts. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
